Protagonist Therapeutics Appoints Bryan Giraudo to Board of Directors

NEWARK, Calif., May 16, 2018 -- (Healthcare Sales & Marketing Network) -- Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced the appointment of Bryan Giraudo to its Board of Directors. Mr. Giraudo currently serves as Chief Financial Officer of ... Biopharmaceuticals, Gastroenterology, Personnel Protagonist Therapeutics, inflammatory bowel disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news